Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-25

FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for liraglutide submitted by Teva Pharmaceuticals USA, Inc. The approval updates the product’s labeling and/or indicatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

SUPPL AP for LIRAGLUTIDE (LIRAGLUTIDE)